Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11842 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1854 Views
-
Last post by NHE
-
- 0 Replies
- 1542 Views
-
Last post by NHE
-
- 4 Replies
- 1553 Views
-
Last post by NHE
-
- 0 Replies
- 1253 Views
-
Last post by NHE
-
- 0 Replies
- 1586 Views
-
Last post by NHE
-
- 0 Replies
- 2050 Views
-
Last post by frodo
-
- 0 Replies
- 2121 Views
-
Last post by NHE
-
- 0 Replies
- 1692 Views
-
Last post by NHE